These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30963195)

  • 1. [Gadolinium deposition-"gadolinium deposition disease"].
    Raczeck P; Fries P; Bücker A; Schneider G
    Radiologe; 2019 May; 59(5):435-443. PubMed ID: 30963195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents.
    Runge VM
    Invest Radiol; 2017 Jun; 52(6):317-323. PubMed ID: 28368880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
    Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
    Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium tissue deposition in brain and bone.
    Murata N; Murata K; Gonzalez-Cuyar LF; Maravilla KR
    Magn Reson Imaging; 2016 Dec; 34(10):1359-1365. PubMed ID: 27720805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?
    Layne KA; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2020 Mar; 58(3):151-160. PubMed ID: 31663374
    [No Abstract]   [Full Text] [Related]  

  • 6. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging.
    Marasini R; Thanh Nguyen TD; Aryal S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1580. PubMed ID: 31486295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
    Delfino R; Biasotto M; Candido R; Altissimo M; Stebel M; Salomè M; van Elteren JT; Vogel Mikuš K; Zennaro C; Šala M; Addobbati R; Tromba G; Pascolo L
    Toxicol Lett; 2019 Feb; 301():157-167. PubMed ID: 30476537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dechelation (Transmetalation): Consequences and Safety Concerns With the Linear Gadolinium-Based Contrast Agents, In View of Recent Health Care Rulings by the EMA (Europe), FDA (United States), and PMDA (Japan).
    Runge VM
    Invest Radiol; 2018 Oct; 53(10):571-578. PubMed ID: 30130320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium in Medical Imaging-Usefulness, Toxic Reactions and Possible Countermeasures-A Review.
    Blomqvist L; Nordberg GF; Nurchi VM; Aaseth JO
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
    Telgmann L; Sperling M; Karst U
    Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
    Thakral C; Alhariri J; Abraham JL
    Contrast Media Mol Imaging; 2007 Jul; 2(4):199-205. PubMed ID: 17712863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL; Thakral C
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Retention and Toxicity-An Update.
    Ramalho M; Ramalho J; Burke LM; Semelka RC
    Adv Chronic Kidney Dis; 2017 May; 24(3):138-146. PubMed ID: 28501075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
    Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
    Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks.
    Unruh C; Van Bavel N; Anikovskiy M; Prenner EJ
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of gadolinium compounds used in magnetic resonance imaging: a critical review and the recommendations of regulatory agencies.
    Martí-Bonmatí L; Martí-Bonmatí E
    Radiologia; 2017; 59(6):469-477. PubMed ID: 29110904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.